SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-006580
Filing Date
2015-08-11
Accepted
2015-08-11 16:06:06
Documents
4
Period of Report
2015-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501868_8k.htm 8-K 17569
2 EXHIBIT 99.1 t1501868_ex99-1.htm EX-99.1 107758
3 GRAPHIC logo99-1a.jpg GRAPHIC 9965
4 GRAPHIC logo99-1b.jpg GRAPHIC 3354
  Complete submission text file 0001571049-15-006580.txt   145173
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 151043948
SIC: 2834 Pharmaceutical Preparations